Company
Last deal
$9.2M
Local Amount - CHF 8.5M
Amount
Series B
Stage
20.12.2022
Date
9
all rounds
$16.5M
Total amount
General
About Company
Resilell offers a diagnostic device that quickly determines the most effective antibiotic treatment for patients.
Industry
Sector :
Subsector :
founded date
01.01.2018
Number of employees
Company Type
For Profit
Last funding type
Series B
IPO status
Private
Contacts
location
Phone number
Website URL